1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study
(2025) In European Urology Oncology
- Contribution to journal › Article
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
(2025) In Urologic Oncology: Seminars and Original Investigations
- Contribution to journal › Article
- 2024
-
Mark
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium
- Contribution to journal › Scientific review
- 2023
-
Mark
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
- Contribution to journal › Article
-
Mark
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making : Proposal from the European Association of Urology Guidelines Panel
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain : A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
- Contribution to journal › Scientific review
-
Mark
suPARnostic : an advanced predictive tool for detecting recurrence in renal cell carcinoma
- Contribution to journal › Article
-
Mark
The need for core outcome sets in renal cancer clinical effectiveness research
- Contribution to journal › Debate/Note/Editorial